Table 4 Risk factors for uveal involvement*.
| Hazard ratio | SE | p Value | 95% CI | |
|---|---|---|---|---|
| Patient characteristics: | ||||
| Age (per 10 years) | 1.328 | 0.201 | 0.061 | 0.987 to 1.786 |
| Female v male | 0.277 | 0.207 | 0.085 | 0.064 to 1.195 |
| Leprosy characteristics: | ||||
| Classification | ||||
| BL v LL | 3.289 | 3.384 | 0.247 | 0.438 to 24.707 |
| Duration of disease | ||||
| Duration ⩾1 year v <1 year | 1.082 | 0.478 | 0.859 | 0.455 to 2.570 |
| Reaction | ||||
| Type I reaction at enrolment | 0.939 | 0.526 | 0.910 | 0.313 to 2.812 |
| Type II reaction at enrolment | 1.056 | 1.447 | 0.968 | 0.072 to 15.482 |
| History of face patch v no face patch | 1.088 | 0.261 | 0.726 | 0.680 to 1.7401 |
| Smear | ||||
| Bacterial index at enrolment | 0.728 | 0.145 | 0.111 | 0.493 to 1.076 |
| Smear positive v smear negative | 0.990 | 0.552 | 0.985 | 0.332 to 2.953 |
| Deformity at enrolment | ||||
| Hand deformity | ||||
| Grade 1 deformity v no deformity | 1.351 | 0.815 | 0.618 | 0.414 to 4.404 |
| Grade 2 deformity v no deformity | 2.844 | 1.746 | 0.089 | 0.854 to 9.474 |
| Leg deformity | ||||
| Grade 1 deformity v no deformity | 0.941 | 0.477 | 0.904 | 0.348 to 2.542 |
| Grade 2 deformity v no deformity | 3.696 | 2.900 | 0.096 | 0.794 to 17.199 |
| Both hand and leg deformity | ||||
| Grade 2 deformity v no grade 2 deformity in all limbs | 4.596 | 3.431 | 0.041 | 1.064 to 19.852 |
*SE, standard error; 95% CI, 95% confidence interval; BL, borderline lepromatous leprosy; LL, lepromatous leprosy; uveal involvement includes flare and cell, keratic precipitates, and iris atrophy.